CARDIOVASCULAR [bdsy]
Effect [qlco]
Selective Estrogen Receptor Modulators [horm, phsu]
Selective Estrogen Receptor Modulators [horm, phsu]
Share [socb]
Biological [bmod]
Effect [qlco]
Cardiovascular system [bdsy]
Hormone replacement therapy [topp]
Hormone replacement therapy [topp]
Selective Estrogen Receptor Modulators [horm, phsu]
Not [ftcn]
Increase [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Not [ftcn]
APPEAR [qlco]
To [qlco]
Increase [ftcn]
C-reactive protein [aapp, imft]
Marker [clna]
tibolone [phsu, strd]
lowers [spco]
High density lipoprotein [aapp, bacs, lipd]
Level [qlco]
animal studies [anim]
CARDIOVASCULAR [bdsy]
consequences [ftcn]
Not [ftcn]
Known [qlco]
If [qlco]
Differential [qlco]
effects [qlco]
Surrogate Endpoints [qlco]
translate [ocac]
Different [qlco]
Clinical [qlco]
CARDIOVASCULAR [bdsy]
Disease Outcome [fndg]
Women [popg]
retrospective [resa]
Analysis [lbpr]
Effect [qlco]
Tamoxifen [orch, phsu]
CARDIOVASCULAR [bdsy]
Outcome [ftcn]
Mixed [ftcn]
Raloxifene [orch, phsu]
Associated [qlco]
Lower [spco]
cardiovascular events [fndg]
High Risk [qlco]
Women [popg]
randomized [resa]
Trial [resa]
In progress [ftcn]
Provide [acty]
More [ftcn]
Definitive [tmco]
Information [idcn]
Role [socb]
Hormone replacement therapy [topp]
Primary Prevention [topp]
Clinical [qlco]
Cardiovascular disease [dsyn]
IMPACT [gngm]
Raloxifene [orch, phsu]
Diverse [qlco]
Population [qnco]
Women [popg]
Clinical [qlco]
Cardiovascular disease [dsyn]
